Advertisement Abbott launches new Vascular Closure System - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Abbott launches new Vascular Closure System

Abbott has launched the StarClose SE Vascular Closure System, a next-generation vessel closure device engineered to enable fast, safe and secure closure of the femoral artery access site following a catheterization procedure. StarClose SE is available in the US and Europe.

StarClose SE, which stands for ‘safe and extravascular, builds upon the premium design of its predecessor, StarClose, with more ergonomically-friendly design features. StarClose SE utilizes the same nitinol (nickel and titanium) clip technology as StarClose to close the femoral artery access site after a catheterization procedure.

Charles Simonton, chief medical officer of Abbott Vascular, said: “StarClose SE was carefully designed to preserve the safety, reliability and extravascular closure of our first-generation technology, while providing enhanced ease of use for physicians.”